Search
for
Sort by
Research 241–270 of 296
- Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride
- Androgenic alopecia may have evolved to protect men from prostate cancer by increasing skin exposure to ultraviolet radiation
- A review of the treatment of male pattern hair loss
- A concise review- Development of an analytical method and validation of dutasteride
- Novel agents for the treatment of alopecia
- Phytotherapy in Trichology: A Review
- Scalp Biophysical Characteristics in Males with Androgenetic Alopecia: A Comparative Study with Healthy Controls
- Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
- Trailing the Path to Preventive Oncology
- Minimally Invasive Non-Surgical Therapies for Androgenetic Alopecia: A Narrative Review of Clinical Evidence for Regenerative and Locally Acting Antiandrogen Treatments
- NANOCARRIER-BASED APPROACHES FOR ENHANCED MANAGEMENT OF ANDROGENETIC ALOPECIA: ADVANCEMENTS AND FUTURE PROSPECTS
- Feeding the skin: The emerging role of nutritional intervention in dermatological disorders
- Phytochemicals and novel delivery systems in alopecia management: An integrative review
- Coconut oil works as a gonadal feedback testosterone booster and increases pituitary aromatase (cyp19a1b) expression levels in fugu (Takifugu rubripes)
- Risks and side effects in the medical management of benign prostatic hyperplasia
- Activity of steroid 4 and derivatives 4a–4f as inhibitors of the enzyme 5α-reductase 1
- Inhibition of 5-Alpha Reductase Attenuates Cardiac Oxidative Damage in Obese and Aging Male Rats via the Enhancement of Antioxidants and the p53 Protein Suppression
- The In Vivo and In Vitro Effects of <i>Terminalia bellirica</i> (Gaertn.) Roxb. Fruit Extract on Testosterone-Induced Hair Loss
- Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health
- Endocrine Regulation of Hair Growth and Loss: Current Evidence and Clinical Implications
- Clinical use of 5α-reductase inhibitors
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- Solubilities of Flutamide, Dutasteride, and Finasteride as Antiandrogenic Agents, in Supercritical Carbon Dioxide: Measurement and Correlation
- Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality
- Unravelling the link between insulin resistance and androgen excess
- Modelling androgen synthesis and action during human sexual differentiation
- GABRA2 Alleles Moderate the Subjective Effects of Alcohol, Which are Attenuated by Finasteride
- Isoallopregnanolone reduces tic‐like behaviours in the D1 CT ‐7 mouse model of Tourette syndrome
- Finasteride induced depression: a prospective study
- Debatable Topics in PCOS Patients